Evelo Biosciences, Inc. (EVLO) Social Stream
Evelo Biosciences Inc (EVLO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EVLO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 14 months, EVLO's average price target has gone up $11.3.
EVLO reports an average of 113.27% for its upside potential over the past 43 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EVLO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
EVLO's average broker recommendation rating improved by 0 over the prior 61 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVLO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Evelo Biosciences Inc's variance in analysts' estimates is lower than -97.38% of them.
- In terms of how Evelo Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 193.83% of that group.
- In terms of how Evelo Biosciences Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 155.86% of that group.
- Evelo Biosciences Inc's average analyst price target is greater than 67.01% of Healthcare stocks.
Is EVLO a Buy, Hold or Sell? See the POWR Ratings now!